Abstract
The purpose of this study was to determine the correlation between the prevalence of hepatitis C virus (HCV) infection with duration of drug use and other risk factors among drug users. This survey covered 899 male drug users from Kaohsiung Narcotic Abstention Institute and Kaohsiung prison. The prevalence of positive anti-HCV was 67.2% among intravenous drug users (IVDU) and 14.7% among non-intravenous drug users (non-IVDU). Among intravenous (IV) drug users, age and duration of drug use were independently related to HCV seropositivity. Seroprevalence rate for HCV in the IVDU group increased with increasing duration of injection use within the first seven years of drug use. However, the steepest trajectory in seroprevalence of HCV infection occurred within the first four months. Due to the high rate of HCV infection among drug users, investigation of risk behaviors should be routine in such a group. A high frequency of HCV infection was also found among short-term injectors, which indicated that early risk reduction intervention was an important measure in moderating HCV infection.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Patti AM, Santi AL, Pompa MG, et al. Viral hepatitis and drugs: A continuing problem. Int J Epidemiol 1993; 22: 135–139.
Norkrans G, Frösner G, Hermodsson S, Iwarson S. Multiple hepatitis attacks in drug addicts. JAMA 1980; 243: 1056–1058.
Wright R. Viral hepatitis comparative epidemiology. Brit Med Bull 1990; 46: 548–558.
Girardi E, Zaccarelli M, Tossini G, et al. Hepatitis C virus infection in intravenous drug users: Prevalence and risk factors. Scand J Infect Dis 1990; 22: 751–752.
Donahue JG, Nelson KE, Munoz A, et al. Antibody to hepatitis C virus among cardiac surgery patients, homosexual men, and intravenous drug users in Baltimore, Maryland. Am J Epidemiol 1991; 134: 1206–1211.
Osmond DH, Charlebois E, Sheppard HW, et al. Comparison of risk factors for hepatitis C and hepatitis B virus infection in homosexual men. J Infect Dis 1993; 167: 66–71.
van den Hock JAR, van Haastrecht HJA, Goudsmit J, de Wolf F, Coutinho RA. Prevalence, incidence and risk factors of hepatitis C virus infection among drug users in Amsterdam. J Infect Dis 1990; 162: 823–826.
Bell J, Batey RG, Farrel GC, et al. Hepatitis C virus in intravenous drug users. Med J Aust 1990; 153: 274–276.
Garfein RS, Vlahov D, Galai N, Doherty MC, Nelson KE. Viral hepatitis in short-term injection drug users: The prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. Am J Public Health 1996; 86: 655–661.
Lee SD, Chan CY, Wang YJ, et al. Seroepidemiology of hepatitis C virus infection in Taiwan. Hepatology 1990; 13: 830–833.
Chen DS, Wang JT, Chen PJ, Wang TH, Sung JL. Hepatitis C virus infection in Taiwan. Gastroenterol Jpn 1991; 26(suppl 3): 164–166.
Esteban JI, Viladomiu L, Gonzalez A, et al. Hepatitis C virus antibodies among risk groups in Spain. Lancet 1989; 8: 294–296.
Woodfield DG. Hepatitis C virus (HCV) infections in New Zealand. Gastroenterol Jpn 1991; 26(suppl 3): 189–191.
Wang JT, Wang TH, Sheu JC, et al. Hepatitis C virus infection in volunteer blood donors in Taiwan: Evaluation by hepatitis C antibody assays and the polymerase chain reaction. Arch Pathol Lab Med 1993; 117: 152–156.
Chang SJ, Chen HC, Ying J, Lu CF, Ko YC. Risk factors of hepatitis C virus infection in a Taiwanese aboriginal community. Kaohsiung J Med Sci 1996; 12: 241–247.
Alter MJ, Coleman PJ, Alexander WJ, et al. Importance of heterosexual activity in the transmission of hepatitis B and non-A, non-B hepatitis. JAMA 1989; 262: 1201–1205.
Thomas DL, Cannon RO, Shapiro CN, et al. Hepatitis C, hepatitis B, and human immunodeficiency virus infections among non-intravenous drug-using patients attending clinics for sexually transmitted diseases. J Infect Dis 1994; 169: 990–995.
Nakashima K, Kashiwagi S, Hayashi J, et al. Sexual transmission of hepatitis C virus among female prostitutes and patients with sexually transmitted diseases in Fukuoka, Kyushu, Japan. Am J Epidemiol 1992; 136: 1132–1137.
Alter HJ, Purcell RH, Shih JW, et al. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med 1989; 321: 1494–1500.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chang, CJ., Lin, CH., Lee, CT. et al. Hepatitis C virus infection among short-term intravenous drug users in southern Taiwan. Eur J Epidemiol 15, 597–601 (1999). https://doi.org/10.1023/A:1007662315835
Issue Date:
DOI: https://doi.org/10.1023/A:1007662315835